| Net Cash Provided by (Used in) Operating Activities |
-7.6K |
USD |
+43% |
Q2 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q2 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q2 2023 |
Q1 2024 |
| Common Stock, Shares Authorized |
75M |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
6.57M |
shares |
0% |
Q3 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
17.4K |
USD |
|
Q3 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q2 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
16.2K |
USD |
+10.2% |
Q1 2025 |
FY 2025 |
| Depreciation |
175 |
USD |
+202% |
Q2 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
|
Q2 2023 |
Q1 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
16.2K |
USD |
+10.2% |
Q1 2025 |
FY 2025 |
| Additional Paid in Capital |
29.8K |
USD |
0% |
Q3 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2025 |
FY 2025 |